2,287
Views
16
CrossRef citations to date
0
Altmetric
Editorial

Manufacturing of hybrid drug delivery systems by utilizing the fused filament fabrication (FFF) technology

ORCID Icon, ORCID Icon, , , &
Pages 1063-1068 | Received 23 Mar 2020, Accepted 27 May 2020, Published online: 08 Jun 2020

References

  • Mathew E, Pitzanti G, Larrañeta E, et al. 3D printing of pharmaceuticals and drug delivery devices. Pharmaceutics. 2020;12(3):266.
  • Lim SH, Kathuria H, Tan JJY, et al. 3D printed drug delivery and testing systems — a passing fad or the future?. Adv Drug Deliv Rev. 2018;132:139–168.
  • Gioumouxouzis CI, Karavasili C, Fatouros DG. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug Discov Today. 2019;24:636–643.
  • Tan D, Maniruzzaman M, Nokhodchi A. Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery. Pharmaceutics. 2018;10(4):203.
  • Alhnan MA, Okwuosa TC, Sadia M, et al. Emergence of 3D Printed Dosage Forms: opportunities and Challenges. Pharm Res. 2016;33:1817–1832.
  • Uziel A, Shpigel T, Goldin N, et al. Three-dimensional printing for drug delivery devices: a state-of-the-art survey. J 3D Print Med. 2019;3:95–109.
  • Melocchi A, Uboldi M, Maroni A, et al. 3D printing by fused deposition modeling of single- and multi-compartment hollow systems for oral delivery – A review. Int J Pharm. 2020;579:119155.
  • Fu J, Yin H, Yu X, et al. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int J Pharm. 2018;549:370–379.
  • Huanbutta K, Sangnim T. Design and development of zero-order drug release gastroretentive floating tablets fabricated by 3D printing technology. J Drug Deliv Sci Technol. 2019;52:831–837.
  • Reddy Dumpa N, Bandari SA, Repka M. Novel gastroretentive floating pulsatile drug delivery system produced via hot-melt extrusion and fused deposition modeling 3D printing. Pharmaceutics. 2020;12:52.
  • Charoenying T, Patrojanasophon P, Ngawhirunpat T, et al. Fabrication of floating capsule-in- 3D-printed devices as gastro-retentive delivery systems of amoxicillin. J Drug Deliv Sci Technol. 2020;55:101393.
  • Markl D, Zeitler JA, Rasch C, et al. Analysis of 3D prints by X-ray computed microtomography and terahertz pulsed imaging. Pharm Res. 2017;34:1037–1052.
  • Genina N, Boetker JP, Colombo S, et al. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: from drug product design to in vivo testing. J Controlled Release. 2017;268:40–48.
  • Maroni A, Melocchi A, Parietti F, et al. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Controlled Release. 2017;268:10–18.
  • Matijašić G, Gretić M, Vinčić J, et al. Design and 3D printing of multi-compartmental PVA capsules for drug delivery. J Drug Deliv Sci Technol. 2019;52:677–686.
  • Tagami T, Hayashi N, Sakai N, et al. 3D printing of unique water-soluble polymer-based suppository shell for controlled drug release. Int J Pharm. 2019;568:118494.
  • Gioumouxouzis CI, Chatzitaki A-T, Karavasili C, et al. Controlled release of 5-fluorouracil from alginate beads encapsulated in 3D printed pH-responsive solid dosage forms. AAPS PharmSciTech. 2018;19(8):3362–3375.
  • Eleftheriadis GK, Katsiotis CS, Bouropoulos N, et al. FDM-printed pH-responsive capsules for the oral delivery of a model macromolecular dye. Pharm Dev Technol. 2020;25(4):517–523.
  • Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater. 2015;27(47):7847–7853.
  • Smith D, Kapoor Y, Hermans A, et al. 3D printed capsules for quantitative regional absorption studies in the GI tract. Int J Pharm. 2018;550(1–2):418–428.
  • Okwuosa TC, Soares C, Gollwitzer V, et al. On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing. Eur J Pharm Sci. 2018;118:134–143.
  • Linares V, Casas M, Caraballo I. Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery. Eur J Pharm Biopharm. 2019;134:138–143.
  • Centola M, Rainer A, Spadaccio C, et al. Combining electrospinning and fused deposition modeling for the fabrication of a hybrid vascular graft. Biofabrication. 2010;2(1):014102.
  • Rajzer I, Kurowska A, Jabłoński A, et al. Layered gelatin/PLLA scaffolds fabricated by electrospinning and 3D printing- for nasal cartilages and subchondral bone reconstruction. Mater Des. 2018;155:297–306.
  • Fuenmayor E, O’Donnell C, Gately N, et al. Mass-customization of oral tablets via the combination of 3D printing and injection molding. Int J Pharm. 2019;569:118611.
  • Trenfield SJ, Xian Tan H, Awad A, et al. Track-and-trace: novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks. Int J Pharm. 2019;567:118443.
  • Eleftheriadis GK, Ritzoulis C, Bouropoulos N, et al. Unidirectional drug release from 3D printed mucoadhesive buccal films using FDM technology: in vitro and ex vivo evaluation. Eur J Pharm Biopharm. 2019;144:180–192.
  • Araújo M, Sa-Barreto L, Gratieri T, et al., The digital pharmacies era: how 3d printing technology using fused deposition modeling can become a reality. Pharmaceutics. 2019;11(3): 128.
  • Goyanes A, Buanz ABM, Basit AW, et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm. 2014;476(1–2):88–92.
  • Aho J, Bøtker JP, Genina N, et al., Roadmap to 3D-printed oral pharmaceutical dosage forms: feedstock filament properties and characterization for fused deposition modeling. J Pharm Sci. 2019;108(1): 26–35.
  • Edinger M, Bar-Shalom D, Sandler N, et al. QR encoded smart oral dosage forms by inkjet printing. Int J Pharm. 2018;536(1):138–145.
  • Nørfeldt L, Bøtker J, Edinger M, et al., Cryptopharmaceuticals: increasing the safety of medication by a blockchain of pharmaceutical products. J Pharm Sci. 2019;108(9): 2838–2841.
  • Di Prima M, Coburn J, Hwang D, et al. Additively manufactured medical products – the FDA perspective. 3D Print Med. 2016; 2(1). DOI: 10.1186/s41205-016-0005-9
  • Mullard A. 2017 FDA drug approvals. Nat Rev Drug Discov. 2018;17(2):81–85.
  • Mullard A. 2018 FDA drug approvals. Nat Rev Drug Discov. 2019;18(2):85–89.
  • Mullard A. 2019 FDA drug approvals. Nat Rev Drug Discov. 2020;19(2):79–84.
  • Wahlich J, Desai A, Greco F, et al., Nanomedicines for the delivery of biologics. Pharmaceutics. 2019;11(5): 210.
  • [cited 2020 Mar 1]. https://clinicaltrials.gov/.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.